Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results
- PMID: 26113357
- DOI: 10.1007/s11102-015-0661-6
Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results
Abstract
Purpose: Hypopituitarism is a possible complication of the surgical treatment of acromegaly. However, there is a wide variability in the incidence rates of surgery-induced hypopituitarism. The purpose of this study was the systematic collection and synthesis of information on the incidence rates of hypopituitarism, panhypopituitarism, specific axis deficiencies and diabetes insipidus after surgery for acromegaly treatment.
Methods: We systematically reviewed all the papers that have reported pituitary deficits after surgery for acromegaly published up until December 2014, in the PubMed database. We identified 92 studies enrolling 6988 patients. A meta-analysis was performed to evaluate the incidence rates. We also performed several subgroup analyses to evaluate the impact of both surgical technique, and treatment prior to surgery, on the results.
Results: The weighted incidence rates were 12.79 % for hypopituitarism (95 % CI 9.88-16.00 %), 2.50 % for panhypopituitarism (95 % CI 1.24-4.15 %), 6.50 % for ACTH deficiency (95 % CI 4.07-9.44 %), 4.39 % for TSH deficiency (95 % CI 2.99-6.04 %), 6.70 % for FSH/LH deficiency (95 % CI 3.89-10.17 %), 14.95 % for GH deficiency (95 % CI 7.25-24.64 %), 10.05 % for transient (95 % CI 7.18-13.33 %) and 2.42 % for permanent diabetes insipidus (95 % CI 1.70-3.27 %).
Conclusion: Our study provides new data on the incidence rates of hypopituitarism, specific pituitary axis deficiencies and diabetes insipidus after surgical treatment of acromegaly. Somatotroph function appears to be more prone to deficit than the other axes. However, there is a high heterogeneity between studies and several factors may influence the incidence of hypopituitarism.
Keywords: Acromegaly; Diabetes insipidus; Hypopituitarism; Surgery; Transsphenoidal.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD013561. doi: 10.1002/14651858.CD013561.pub2. Cochrane Database Syst Rev. 2024. PMID: 38318883 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2015 Nov 5;2015(11):CD004692. doi: 10.1002/14651858.CD004692.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Nov 24;11:CD004692. doi: 10.1002/14651858.CD004692.pub5. PMID: 26537796 Free PMC article. Updated.
Cited by
-
Complications of acromegaly: thyroid and colon.Pituitary. 2017 Feb;20(1):70-75. doi: 10.1007/s11102-016-0744-z. Pituitary. 2017. PMID: 27631334 Review.
-
Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study.Front Endocrinol (Lausanne). 2021 Oct 7;12:748725. doi: 10.3389/fendo.2021.748725. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34690934 Free PMC article.
-
[Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities].Internist (Berl). 2017 Nov;58(11):1171-1182. doi: 10.1007/s00108-017-0331-z. Internist (Berl). 2017. PMID: 29027568 Review. German.
-
Functioning Pituitary Adenomas - Current Treatment Options and Emerging Medical Therapies.Eur Endocrinol. 2019 Apr;15(1):30-40. doi: 10.17925/EE.2019.15.1.30. Epub 2019 Apr 12. Eur Endocrinol. 2019. PMID: 31244908 Free PMC article. Review.
-
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.Pituitary. 2016 Aug;19(4):448-57. doi: 10.1007/s11102-016-0725-2. Pituitary. 2016. PMID: 27279011 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources